|
|
|
|
|
Teisinis statusas
Patentas neįsigaliojo (pagal Susitarimą)
| (51) | INT.CL. | A61K 31/4704 | |
| A61P 35/00 |
| (11) | Patento numeris | 1267848 |
| (13) | Dokumento rūšis | T |
| (96) | Europos patento paraiškos numeris | 01903785.2 |
| Europos patento paraiškos padavimo data | 2001-02-20 | |
| (97) | Europos patento paraiškos paskelbimo data | 2003-01-02 |
| (45) | Paskelbimo apie Europos patento išdavimą data | 2007-10-17 |
| (46) | Apibrėžties vertimo paskelbimo data |
| (86) | Numeris | PCT/EP2001/001937 |
| Data | 2001-02-20 |
| (87) | Numeris | WO 2001/062234 |
| Data | 2001-08-30 |
| (30) | Numeris | Data | Šalis |
| 184551 P | 2000-02-24 | US |
| (72) |
END, David, William, US
|
| (73) |
Janssen Pharmaceutica NV,
Turnhoutseweg 30, 2340 Beerse,
BE
|
| (54) | DOSING REGIMEN COMPRISING A FARNESYL PROTEIN TRANSFERASE INHIBITOR FOR THE TREATMENT OF CANCER |
| DOSING REGIMEN COMPRISING A FARNESYL PROTEIN TRANSFERASE INHIBITOR FOR THE TREATMENT OF CANCER |